Scizo trial gotta enroll first and all the other stuff before Anavex gets round to publishing results months after the data is in and its only a very small P2 trial to work out dose, so no.
Filing the MAA would be great, but not the price increasing and sustaining news we need. Approval would be and if that happens it will be well into 2025.